CDKN2A and central nervous system cancer: In the present study, using The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), the Memorial Sloan Kettering Cancer Center (MSKCC), and Gene Expression Omnibus (GEO) datasets, the prognostic significance of EGFR and CDKN2A alteration was determined.